Interstitial lung disease: case report

    This is a preview of subscription content, access via your institution.


    1. He Z, et al. Rituximab may cause higher mortality in young autoimmune disease patients with rituximab-induced interstitial lung disease: A case report and systematic review of the literature. International Journal of Clinical Pharmacology and Therapeutics 58: 740-748, No. 12, Dec 2020. Available from: URL: http://doi.org/10.5414/CP203840

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Rituximab. Reactions Weekly 1842, 325 (2021). https://doi.org/10.1007/s40278-021-91061-3

    Download citation